Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Positive opinion for reimbursement of Advate in France

Aug. 18, 2004

Novel factor Xa inhibitors in early development at Boehringer Ingelheim

Aug. 17, 2004

Guilford plans major PCI trials for Aggrastat

Aug. 17, 2004

Ajinomoto presents new prodrugs of factor Xa inhibitors

Aug. 16, 2004

Novel factor Xa and/or factor VIIa inhibitors under study at Aventis

Aug. 16, 2004

European orphan drug designation for acetylsalicylic acid in polycythemia vera

Aug. 12, 2004

Dosing begins in phase I study of the thrombin inhibitor ARC-183

Aug. 11, 2004

Novel PAI-1 inhibitors produced by the microorganism Stachybotris atra

Aug. 11, 2004

Portola licenses Millennium's Factor Xa inhibitor program

Aug. 11, 2004

Emisphere selects formulation of oral heparin

Aug. 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.